(Press-News.org) Worldwide, an estimated, 40 million people live with HIV. Two-thirds of this group on the African continent. In 2022, more than 600,000 people died from HIV-related causes and more than 1.3 million were infected. There is no vaccine against the world's second most deadly infection, after TB. Thanks to a grant from the Bill & Melinda Gates Foundation, Amsterdam UMC's Rogier Sanders leads a project that aims to develop the first effective HIV vaccine.
"We hope to be able to develop a preventative vaccine by designing and testing immunogens that will induce neutralising antibodies. So far, no one has managed this,” says Sanders, Professor of Virology at Amsterdam UMC.
Developing a HIV vaccine has proven, so far, impossible but in Sanders' view there are reasons to be positive. “There’s quite a lot of optimism at the moment in the HIV vaccine field because of developments in early phase research. There are quite some positive results from several Phase I studies on trying to induce broadly neutralizing antibodies,” Sanders explains. “All the vaccines that failed so far have not been able to induce neutralising antibodies, let alone broadly neutralising antibodies. But there’s very nice progress compared to these earlier studies.”
Building on progress
His team, consisting of researchers from Stanford University, Weill Cornell Medical College and the University of Louisiana, aim to build on this 'nice progress' by developing a vaccine that specifically targets rare immune cells that are capable of making antibodies that neutralize the virus. Known as 'Germline Targeting', this process guides the immune system by activating immune cells that have the potential to grow and produce antibodies that react against a HIV infection. This process has already been shown to work, in a study published but another research team in Science, earlier this year.
Sanders’ team are also currently busy with their own study in search of a vaccine that can stimulate immune cells into producing antibodies. The next step is to develop ways of boosting immune response, through a process known as 'priming, shaping and polishing,' where these cells are then guided through a development process so that they can ultimately produce stronger and broader antibodies.
"Think of the human immune cells in terms of a youth football team. First, the germline-targeting vaccine scouts and recruits the talents from this youth team, then once the right cells have been primed, through multiple phases of training, the shaping and polishing vaccines, the talented players are eventually shaped into world class football players,” says Sanders. This process may ultimately lead to immune response that is strong enough to repel a HIV infection and, thus, a fully functioning vaccine.
Unusual features
While this sounds simple, the hunt for an HIV vaccine has puzzled virologists. Since the 1980s, there has still not been a successful phase III study among a large group of subjects. This is mainly due to the unusual properties of HIV. "There are so many things to consider," Sanders explains. "There are a number of reasons why it is so difficult to make a vaccine and one of them is the diversity of the virus. A second difficulty lies in the structural or chemical properties of the protein that surrounds the virus, which is crucial for vaccines."
Sanders' team recently took an important step forward with a 'priming' vaccine that was tested in a phase I study in test subjects in New York, Washington and Amsterdam (at Amsterdam UMC). "We are hopeful that we will eventually succeed in developing an effective vaccine against the many variants of HIV. Hopefully, that will put an end to the ongoing misery that the virus brings," Sanders says.
With the Gates Foundation grant, worth €4.5m, Sanders and the team hope to reach their goals within five years
END
Priming, shaping and polishing: In search of a HIV vaccine
Amsterdam UMC leads a global project to discover a HIV Vaccine that is practical for those in Low and Middle-Income Countries
2024-01-15
ELSE PRESS RELEASES FROM THIS DATE:
Vigilant monitoring is needed to manage cardiac risks in patients using antipsychotics, doctors say
2024-01-15
Philadelphia, January 15, 2024 – The use of the antipsychotic drugs quetiapine and haloperidol is associated with an increased risk of ventricular arrhythmias and sudden cardiac death (SCD) caused by drug-induced QT prolongation, reports a new study in Heart Rhythm, the official journal of the Heart Rhythm Society, the Cardiac Electrophysiology Society, and the Pediatric & Congenital Electrophysiology Society, published by Elsevier. Caution is advised to manage cardiac risks in patients prescribed ...
Singapore study reveals impact of early life adversity on a child’s brain development
2024-01-15
Leveraging neuroimaging data from the Growing Up in Singapore Towards healthy Outcomes (GUSTO) cohort, researchers from A*STAR’s Singapore Institute for Clinical Sciences (SICS) identified an association between early life adversity and the pace of brain development in childhood.
SINGAPORE – A study led by researchers from A*STAR's Singapore Institute for Clinical Sciences (SICS) has found evidence suggesting that children exposed to elevatec levels of early life adversity (ELA) exhibit an accelerated pattern of brain development during the preschool years. When exposed to ELA, such as a mother's mental and ...
Researchers propose revised scoring system for recognising outstanding NHS clinicians
2024-01-15
A team of researchers has developed a new scoring system for a nationwide scheme, overseen by the Advisory Committee on Clinical Impact Awards (ACCIA), to recognise and reward senior doctors and dentists in England and Wales.
There has been a scheme in place since 1948 to reward senior clinicians who make an outstanding contribution to supporting the delivery of NHS goals. The awards have been known, through various iterations, as merit awards, clinical excellence awards, and, most recently, clinical impact awards.
Published ...
Few older adults use direct-to-consumer health services; many who do don’t tell their regular provider
2024-01-14
Only a small percentage of older Americans have jumped on the rising trend of getting health care services and prescriptions directly from an online-only company, rather than seeing their usual health care providers in person or via telehealth, a new poll finds.
But that could change rapidly, the University of Michigan survey suggests.
In all, 7.5% of people between the ages of 50 and 80 have used at least one direct-to-consumer health care service from an online-only provider, according to the new findings from the National Poll on Healthy Aging.
Of those who did ...
Loss of cells in pancreas in the elderly may cause age-related diabetes
2024-01-13
Tokyo, Japan – Researchers from Tokyo Metropolitan University have studied pancreatic islet cell loss in people with no previous pancreatic problems. They identified key trends in the types of cells lost due to islet cell loss in different age groups and sexes, finding that ICL in the elderly population was largely due to insulin-producing beta cell loss. This may be the cause of age-related diabetes and help inform new preventative treatments.
The pancreas is an incredibly important part of the human digestive system, particularly for regulating blood sugar levels by secreting the hormone insulin. ...
African women living with HIV have an effective option to prevent malaria during pregnancy
2024-01-13
In women living with HIV, preventive treatment with DHA-PPQ is a safe and effective strategy to prevent malaria during pregnancy, according to the final results of MAMAH, a clinical trial funded by the European & Developing Countries Clinical Trials Partnership (EDCTP) and coordinated by the Barcelona Institute for Global Health (ISGlobal), an institution supported by “la Caixa” Foundation. The study, published in the Lancet Infectious Diseases, could help protect the health of the estimated one million pregnant women who suffer from a double infection with malaria ...
The fate of novel ideas
2024-01-13
Innovation may be what drives progress in the arts, business, sciences and technology, but the novel ideas that drive innovation often face headwinds that hinder or even prevent their adoption.
Why did some good ideas, such as hand sanitizing in 19th-century hospitals or racial integration in the 20th century, take years to win widespread embrace? University of Utah postdoctoral researcher Wayne Johnson set out to identify the hurdles.
His research team’s program of five studies, which featured analyses of evaluations of films screened at Utah’s Sundance Film ...
Are bugs bugging humans or the other way around? Study reveals a few surprises
2024-01-13
Insects and spiders often receive little attention from people, except when we’re swatting them away. However, as arthropods — creatures distinguished by a hard exoskeleton and jointed legs— they play an essential role in sustaining the ecosystems humans rely on. Remarkably, arthropods make up approximately 84% of all known animal species.
A study published recently in Scientific Reports reveals how human activity affects biodiversity among arthropods and how nonbiological factors, such as daily temperature swings and proximity to the ocean, affect arthropod biodiversity in urban areas.
The research uncovered a few ...
Could an already approved drug cut down on opioid use after surgery?
2024-01-12
Researchers in the Department of Anesthesia and Perioperative Medicine at the Medical University of South Carolina (MUSC) have found that an FDA-approved drug may help to decrease pain after surgery. In the pilot study published in Pain Management, spinal surgery patients who received N-acetylcysteine (NAC) during surgery in addition to standard pain control treatments reported lower pain scores and requested fewer opioids after surgery than patients given a placebo.
Opioids are often given for a short time after ...
HOXA9 tracking reveals RBM5 dual function and therapeutic potential for acute myeloid leukemia
2024-01-12
(Memphis, Tenn – January 12th, 2024) The protein HOXA9 is overexpressed in most acute myeloid leukemia (AML) cases and is associated with poor patient outcomes. However, HOXA9 is a difficult protein to target therapeutically, so researchers at St. Jude Children’s Research Hospital looked for ways to extinguish it indirectly. Using CRISPR/Cas9 screening, the researchers identified RBM5, demonstrating a causative link between RBM5 expression and leukemia cell proliferation. This link is driven by a novel dual function of RBM5 as both a DNA and RNA handler ...
LAST 30 PRESS RELEASES:
MSU team develops scalable climate solutions for agricultural carbon markets
Playing an instrument may protect against cognitive aging
UNM study finds link between Grand Canyon landslide and Meteor Crater impact
Ultra-hot Jupiter’s death spiral could reveal stellar secrets
You only get one brain! The best helmet material for protecting your noggin
Neurodegeneration and stroke after GLP-1RAs in diabetes and obesity
Pediatric COVID-19 hospitalization trends by race and ethnicity, 2020-2023
Research spotlight: New genetic roadmap offers insights into obesity and diabetes
Fred Hutch leads new Vanguard Study for Cancer Screening Research Network
‘Mismatched’ transplants now safe, effective for blood cancer patients, study finds
New research helps narrow down uncertainties in near-term precipitation projections for the Asian Water Tower
AI tool accurately detects tumor location on breast MRI
Researchers use OCT imaging to uncover how the fallopian tube transports embryos
PolyU secures RGC theme-based research scheme funding to develop cost-effective and sustainable Co-GenAI model
Van Andel Institute scientists develop technique for high-resolution single cell epigenetic analysis
The Lundquist Institute wins multi-year NIH grant exceeding $11 million to transform diagnosis and treatment of deadly mucormycosis
Review suggests ending adult boosters for tetanus, diphtheria
ESMT Berlin welcomes Rebecca Schaumberg to faculty
Blocking a little-known protein may offer new hope for devastating lung disease
Medieval medicine was smarter than you think – and weirdly similar to TikTok trends
FAU receives NIH grant to investigate amphetamine addiction
Realizing on-site carbon nanotube photo-thermoelectric imaging
Most of us love memes. But are they a form of comics?
Novel biosensor allows real-time monitoring of sucrose uptake in plants
Korea University researchers reveal revealing how WEE1 drives cancer resistance to immunotherapy
Pusan National University researchers develop breakthrough deep learning model that enhances handheld 3D medical imaging
SLAS Discovery and SLAS Technology demonstrate research impact with 2024 impact factors
Disease-causing bacteria can deal with stink as long as they get a meal
Mapping the metabolism of blood stem cells
UK air quality improved since 2015 but targets still missed
[Press-News.org] Priming, shaping and polishing: In search of a HIV vaccineAmsterdam UMC leads a global project to discover a HIV Vaccine that is practical for those in Low and Middle-Income Countries